Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 11/20 | 0.40 |
| ▸ | SLC5A1 | P13866 | 7/20 | 0.39 |
| ▸ | PYGB | P11216 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8199991 | 1.00 | SLC5A2 (0.40) | SLC5A2SLC5A1PYGB | |
| SCHEMBL8823097 | 0.79 | SLC5A1 (0.36) | SLC5A2SLC5A1 | |
| SCHEMBL18316490 | 0.79 | SLC5A2 (0.40) | SLC5A2SLC5A1 | |
| SCHEMBL20723768 | 0.79 | SLC5A2 (0.40) | SLC5A2SLC5A1 | |
| SCHEMBL20723767 | 0.79 | SLC5A2 (0.40) | SLC5A2SLC5A1 | |
| SCHEMBL4279547 | 0.79 | SLC5A2 (0.40) | SLC5A2SLC5A1 | |
| SCHEMBL9094088 | 0.78 | SLC5A2 (0.40) | SLC5A2SLC5A1 | |
| SCHEMBL3956073 | 0.78 | SLC5A2 (0.40) | SLC5A2SLC5A1PYGB | |
| SCHEMBL8731248 | 0.78 | SLC5A2 (0.40) | SLC5A2SLC5A1 | |
| SCHEMBL8576401 | 0.78 | SLC5A2 (0.40) | SLC5A2SLC5A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0650732-B1 | NOVEL MEDICINAL COMPOSITION | KIRIN BREWERY (JP) | 2001-04-04 | — | — | EP | disclosed |
| US-6071884-A | ADMINISTERING TO THE PATIENT ATLEAST ONE ALPHA-GALACTOSYLCERAMIDE TO TREAT THROMBOCYTOPENIA | KIRIN BEER KABUSHIKI KAISHA (JP) | 2000-06-06 | — | — | US | disclosed |
| EP-0666268-B1 | NOVEL SPHINGOGLYCOLIPID AND USE THEREOF | KIRIN BREWERY (JP) | 2000-04-19 | — | — | EP | disclosed |
| US-6017892-A | Method for accelerating marrow cell proliferation | KIRAN BEER KABUSHIKI KAISHA (JP) | 2000-01-25 | — | — | US | disclosed |
| US-5936076-A | ANTITUMOR/ANTICARCINOGENIC AGENTS; IMMUNOSTIMULATORS; THERAPY AGAINST INFECTIONS, AQUIRED IMMUNE DEFICIENCY SYNDROME | KIRIN BEER KABUSHIKI KAISHA (JP) | 1999-08-10 | — | — | US | disclosed |
| EP-0609437-B1 | NOVEL SPHINGOGLYCOLIPID AND USE THEREOF | KIRIN BREWERY (JP) | 1999-07-07 | — | — | EP | disclosed |
| US-5849716-A | Sphingoglycolipids, their preparation, and therapeutic methods of use | KIRIN BEER KABUSHIKI KAISHA (JP) | 1998-12-15 | — | — | US | disclosed |
| US-5767092-A | Treatment of radiation-damaged bone marrow using galactosyl ceramides | KIRIN BEER KABUSHIKI KAISHA (JP) | 1998-06-16 | — | — | US | disclosed |
| EP-0666268-A1 | NOVEL SHINGOGLYCOLIPID AND USE THEREOF | KIRIN BEER KABUSHIKI KAISHA (JP) | 1995-08-09 | — | — | EP | disclosed |
| EP-0650732-A1 | NOVEL MEDICINAL COMPOSITION | KIRIN BEER KABUSHIKI KAISHA (JP) | 1995-05-03 | — | — | EP | disclosed |
| EP-0609437-A1 | NOVEL SPHINGOGLYCOLIPID AND USE THEREOF | KIRIN BEER KABUSHIKI KAISHA (JP) | 1994-08-10 | — | — | EP | disclosed |